Literature DB >> 14654662

Cognitive and behavioral development in maternal phenylketonuria offspring.

Susan E Waisbren1, Colleen Azen.   

Abstract

OBJECTIVE: To assess cognitive and behavioral outcome in treated maternal phenylketonuria (PKU) offspring.
METHODS: In this prospective, longitudinal study, 228 children who were born to mothers with treated PKU or untreated mild hyperphenylalaninemia were compared with 70 control subjects at 7 years of age.
RESULTS: Offspring cognitive outcome negatively correlated with the number of gestational weeks that elapsed until maternal metabolic control was achieved (r = -0.61). Behavioral outcome was similarly affected. Postnatal measurement of stimulation in the home was also related to offspring IQ.
CONCLUSIONS: Children who are born to mothers who have PKU and attain metabolic control before or very early in pregnancy seem to begin life with undiminished potential. Delay in attainment of maternal metabolic control is associated with declines in offspring developmental outcome. The postnatal environment also significantly affects outcome. Interventions to improve dietary compliance before and throughout pregnancy as well as interventions to improve the postnatal home environment may reduce the risks associated with maternal PKU.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 14654662

Source DB:  PubMed          Journal:  Pediatrics        ISSN: 0031-4005            Impact factor:   7.124


  7 in total

Review 1.  Food products made with glycomacropeptide, a low-phenylalanine whey protein, provide a new alternative to amino Acid-based medical foods for nutrition management of phenylketonuria.

Authors:  Sandra C van Calcar; Denise M Ney
Journal:  J Acad Nutr Diet       Date:  2012-08       Impact factor: 4.910

2.  Maternal Phenylketonuria: Long-term Outcomes in Offspring and Post-pregnancy Maternal Characteristics.

Authors:  S E Waisbren; F Rohr; V Anastasoaie; M Brown; D Harris; A Ozonoff; S Petrides; A Wessel; H L Levy
Journal:  JIMD Rep       Date:  2015-02-25

3.  Maternal hyperphenylalaninemia: rapid achievement of metabolic control predicts overall control throughout pregnancy.

Authors:  Teresa Martino; Celide Koerner; Gayane Yenokyan; Julie Hoover-Fong; Ada Hamosh
Journal:  Mol Genet Metab       Date:  2013-02-19       Impact factor: 4.797

Review 4.  The complete European guidelines on phenylketonuria: diagnosis and treatment.

Authors:  A M J van Wegberg; A MacDonald; K Ahring; A Bélanger-Quintana; N Blau; A M Bosch; A Burlina; J Campistol; F Feillet; M Giżewska; S C Huijbregts; S Kearney; V Leuzzi; F Maillot; A C Muntau; M van Rijn; F Trefz; J H Walter; F J van Spronsen
Journal:  Orphanet J Rare Dis       Date:  2017-10-12       Impact factor: 4.123

5.  Reproductive experience of women living with phenylketonuria.

Authors:  Suzanne Ford; Mike O'Driscoll; Anita MacDonald
Journal:  Mol Genet Metab Rep       Date:  2018-11-02

6.  Maternal phenylketonuria syndrome: studies in mice suggest a potential approach to a continuing problem.

Authors:  William L Zeile; Helen C McCune; Donald G Musson; Brian O'Donnell; Charles A O'Neill; Laurie S Tsuruda; Roberto T Zori; Philip J Laipis
Journal:  Pediatr Res       Date:  2018-01-31       Impact factor: 3.756

Review 7.  Contributions of a Child's Built, Natural, and Social Environments to Their General Cognitive Ability: A Systematic Scoping Review.

Authors:  Jazmin Del Carmen Ruiz; James J Quackenboss; Nicolle S Tulve
Journal:  PLoS One       Date:  2016-02-03       Impact factor: 3.240

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.